Nabi BioPharmaceuticals dedicated its new 12,000-sf vaccine manufacturing facility in Boca Raton, Fla., in June, 2005. Sited at the company's existing headquarters, the $20-million facility will produce StaphVax, a vaccine for the prevention of hospital-born staph infections.
Biotechnology firm Genitope is relocating its headquarters and manufacturing operations from Redwood City to 220,0000 sf in Fremont, Calif. Genitope has signed two fifteen and a half year leases for two facilities in the Ardenwood Technology Park at $2.35 per square foot or $517,000 per month. The facilities, which will cost $60 million to build out, will be occupied by Genitope upon completion of construction in 2006.
Bayer Healthcare has completed a 100,000-sf office and laboratory facility in Norwood, Mass. Designed by Margulies & Associatesof Boston, the new space consists of 80,000 sf of administrative offices and support areas as well as 20,000 sf of laboratories. Supporting the company's Diagnostics Division, the facility includes visitor and training labs, a test methods lab, an analytical lab, a systems engineering lab, storage for chemicals, and controlled-temperature storage coolers.
The $100 million California Institute for Quantitative Biomedical Research is nearing completion at the Mission Bay campus in South San Francisco. The 153,000-sf facility is the first of four buildings that will make up the institute known as QB3 and is connected to U.C. San Francisco's Genentech Hall on all five stories. The Mission Bay facility will house a magnetic resonance imaging machine, a high through-put screening facility, a 250,000-compound chemical library for drug development, and 8,000 CPUs.
Translational Genomics (TGen) will officially dedicate its new $46 million headquarters on March 22, 2005. Located in Phoenix, Ariz., the TGen headquarters is sited in a 173,000-sf building, the first in a new downtown campus called the Phoenix Bioscience Center at Cooper Square. Other tenants in the building include the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), occupying the entire 23,000-sf second floor, and the International Genomics Consortium (IGC).
Clark University will dedicate the new Cathy '83 and Marc '81 Center for Bioscience on April 28, 2005. Designed by Tsoi/Kobus and Associates of Cambridge, the 50,000-sf facility houses two classrooms; twelve research labs; seven teaching labs; two conference rooms; fourteen faculty offices; a sequencing facility; a dark room; and three lounges.
Ground has been broken on a new 170,000-sf research laboratory and office facility in St. Louis for the Center of Research, Technology and Entrepreneurial Exchange (CORTEX), a non-profit collaboration of Washington University, St. Louis University, The Barnes-Jewish Hospital Foundation, and the University of Missouri-St. Louis. Designed by HOK, the $36 million project incorporates sustainable design principles and will pursue LEEDTM certification from the U.S.
Genentech has signed a lease for 780,000 sf in South San Francisco, which may be the largest single lease ever penned in the northern California Bay Area. Developer Slough Estates will construct the three-, four-, and eight-story life science facilities in two phases over the next four years. Construction cost is estimated at approximately $325 million. The project will consist of roughly 40 percent office and 60 percent laboratory space.
FivePrime Therapeutics will sublease an entire floor in the new 190,000-sf J. David Gladstone Institutes building at Mission Bay in San Francisco. The Gladstone building was dedicated on December 6, 2004. The facility will enable FivePrime to develop new protein and antibody therapeutics utilizing an accelerated drug discovery approach. FivePrime will relocate its South San Francisco operations to the Gladstone building in San Francisco, a city which has a payroll tax exemption for biotech companies.
The University of Pennsylvania has selected Skanska USA Building to construct the new Skirkanich Hall Bioengineering Building in Philadelphia. Skirkanich Hall will be approximately 63,000 sf and will include labs, classrooms, offices, and support facilities that will be connected to the Moore and Towne buildings on campus. Work also includes renovations within the two buildings to accommodate the tie-ins, as well as infrastructure improvements.
Design of Roche Diagnostic 's new 440,000-sf PCR Manufacturing Center in Branchburg, N.J., is nearing completion. PCR (Polymerase Chain Reaction) is leading-edge technology in the field of molecular diagnostics. The facility will include a new state-of-the-art 230,000-sf pharmaceutical manufacturing center, a 32,000-sf office building (completed), and the renovation of a 180,000-sf existing laboratory and office headquarters for Roche Molecular Systems. The manufacturing facility is slated for completion in November 2004.
The University of Maryland, Baltimore has issued a request for proposals to develop the second building on its bioscience campus in downtown Baltimore. Construction on the 110,000-sf facility is expected to begin in spring 2005. Construction of a 600-car parking garage at the site is slated to begin by the end of October 2004. Buildout on the first 120,000-sf building on the bioscience campus, housing office and lab space, will be completed by summer 2005.
Boston University Medical Center, Boston University, and the city of Boston celebrated the topping off of the eight-story BioSquare 3 in Boston in September 2004. Being the third lab and research facility on the 14-acre campus, the 160,000-sf building is 60 percent pre-leased to Boston University and Boston University Medical Center. Completion is expected in fall 2005.
Genentech is planning to develop up to 600,000 sf of offices and labs on 20 acres to be purchased in Oyster Point near its South San Francisco headquarters. Genentech currently occupies 33 facilities in South San Francisco, and has applied with the city to expand its 72-acre campus to 111 acres.
Rensselaer Polytechnic Institute opened the $80 million, 218,000-sf Center for Biotechnology and Interdisciplinary Studies on its Troy, N.Y., campus on September 10, 2004. The facility will accommodate research in drug synthesis, tissue repair and replacement, and biosensors and monitoring. Including 67,000-sf of lab and lab support space and 104,000-sf of public and administrative space, the four-story facility was designed by architects Burt Hill and Bohlin Cywinkski Jackson.
